DOP15 Results of a Pragmatic Multicentred Randomised Controlled Trial Investigating the Use of Personalised Golimumab Dosing in Ulcerative Colitis: the GOAL-ARC Study (GLM Dose Optimisation to Adequate Levels to Achieve Response in Colitis)
JOURNAL OF CROHNS & COLITIS(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要